| Ident. | Authors (with country if any) | Title |
|---|
| 000055 (2018) |
Sarah A. Buchan [Canada] ; Stephanie Booth [Canada] ; Allison N. Scott [Canada] ; Kimberley A. Simmonds [Canada] ; Lawrence W. Svenson [Canada] ; Steven J. Drews [Canada] ; Margaret L. Russell [Canada] ; Natasha S. Crowcroft [Canada] ; Mark Loeb [Canada] ; Bryna F. Warshawsky [Canada] ; Jeffrey C. Kwong [Canada] | Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, Canada: A Canadian Immunization Research Network (CIRN) Study. |
| 000081 (2017) |
Jefferson J S. Santos [États-Unis] ; Adebimpe O. Obadan [États-Unis] ; Stivalis Cardenas Garcia [États-Unis] ; Silvia Carnaccini [États-Unis] ; Darrell R. Kapczynski [États-Unis] ; Mary Pantin-Jackwood [États-Unis] ; David L. Suarez [États-Unis] ; Daniel R. Perez [États-Unis] | Short- and long-term protective efficacy against clade 2.3.4.4 H5N2 highly pathogenic avian influenza virus following prime-boost vaccination in turkeys. |
| 000085 (2017) |
Edward W. Thommes [Canada] ; Morgan Kruse [États-Unis] ; Michele Kohli [Canada] ; Rohita Sharma [Canada] ; Stephen G. Noorduyn [Canada] | Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines. |
| 000141 (2016) |
Mark Loeb [Canada] ; Margaret L. Russell [Canada] ; Vanessa Manning [Canada] ; Kevin Fonseca [Canada] ; David J D. Earn [Canada] ; Gregory Horsman [Canada] ; Khami Chokani [Canada] ; Mark Vooght [Canada] ; Lorne Babiuk [Canada] ; Lisa Schwartz [Canada] ; Binod Neupane [Canada] ; Pardeep Singh [Canada] ; Stephen D. Walter [Canada] ; Eleanor Pullenayegum [Canada] | Live Attenuated Versus Inactivated Influenza Vaccine in Hutterite Children: A Cluster Randomized Blinded Trial. |
| 000149 (2016) |
Debbie L. Becker [Canada] ; Ayman Chit [États-Unis, Canada] ; Carlos A. Diazgranados [États-Unis] ; Michael Maschio [Canada] ; Eddy Yau [Canada] ; Michael Drummond [Royaume-Uni] | High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors. |
| 000157 (2016) |
Quentin Canelle [Belgique] ; Walthère Dewé [Belgique] ; Bruce L. Innis [Belgique] ; Robbert Van Der Most [Belgique] | Evaluation of potential immunogenicity differences between Pandemrix™ and Arepanrix™. |
| 000188 (2015) |
Jeffrey C. Kwong [Canada] ; Jennifer A. Pereira [Canada] ; Susan Quach [Canada] ; Rosana Pellizzari [Canada] ; Edwina Dusome [Canada] ; Margaret L. Russell [Canada] ; Jemila S. Hamid [Canada] ; Yael Feinberg [Canada] ; Anne-Luise Winter [Canada] ; Jonathan B. Gubbay [Canada] ; Brittany Sirtonski [Canada] ; Deanna Moher [Canada] ; Doug Sider [Canada] ; Michael Finkelstein [Canada] ; Mark Loeb [Canada] | Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) pilot study: a cluster randomized trial. |
| 000189 (2015) |
Jeffrey C. Kwong [Canada] ; Jennifer A. Pereira [Canada] ; Susan Quach [Canada] ; Rosana Pellizzari [Canada] ; Edwina Dusome [Canada] ; Margaret L. Russell [Canada] ; Jemila S. Hamid [Canada] ; Yael Feinberg [Canada] ; Anne-Luise Winter [Canada] ; Jonathan B. Gubbay [Canada] ; Brittany Sirtonski [Canada] ; Deanna Moher [Canada] ; Doug Sider [Canada] ; Michael Finkelstein [Canada] ; Mark Loeb [Canada] | Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) cluster randomized trial: Pilot results from a household surveillance study to assess direct and indirect protection from influenza vaccination. |
| 000204 (2015) |
Joanne M. Langley [Canada] ; Long Wang [États-Unis] ; Naresh Aggarwal [Canada] ; Agustin Bueso [Honduras] ; Vijayalakshmi Chandrasekaran [États-Unis] ; Luis Cousin [Honduras] ; Scott A. Halperin [Canada] ; Ping Li [États-Unis] ; Aixue Liu [États-Unis] ; Shelly Mcneil [Canada] ; Lourdes Pe A Mendez [République dominicaine] ; Luis Rivera [République dominicaine] ; Bruce L. Innis [États-Unis] ; Varsha K. Jain [États-Unis] | Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012-2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical Trial. |
| 000234 (2015) |
Ayman Chit [Canada] ; Julie Roiz [Royaume-Uni] ; Samuel Aballea [France] | An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model. |
| 000236 (2015) |
Laura Goodliffe [Canada] ; Brenda L. Coleman [Canada] ; Allison J. Mcgeer [Canada] | Acceptance of intradermal inactivated influenza vaccines among hospital staff following 2 seasonal vaccination campaigns. |
| 000247 (2014) |
Jacques Montplaisir [Canada] ; Dominique Petit [Canada] ; Marie-Josée Quinn [Canada] ; Manale Ouakki [Canada] ; Geneviève Deceuninck [Canada] ; Alex Desautels [Canada] ; Emmanuel Mignot [États-Unis] ; Philippe De Wals [Canada] | Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec. |
| 000260 (2014) |
Mark Bigham [Canada] ; Arjuna Ponnampalam [Canada] | Neutralization positive but apparent false-positive hepatitis B surface antigen in a blood donor following influenza vaccination. |
| 000326 (2013) |
David W. Scheifele [Canada] ; Marc Dionne ; Brian J. Ward ; Curtis Cooper ; Otto G. Vanderkooi ; Yan Li ; Scott A. Halperin | Safety and immunogenicity of 2010–2011 A/H1N1pdm09-containing trivalent inactivated influenza vaccine in adults previously given AS03-adjuvanted H1N1 2009 pandemic vaccine: results of a randomized trial. |
| 000367 (2013) |
Benjamin J. Ridenhour [États-Unis] ; Michael A. Campitelli ; Jeffrey C. Kwong ; Laura C. Rosella ; Ben G. Armstrong ; Punam Mangtani ; Andrew J. Calzavara ; David K. Shay | Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged ≥ 65 years: estimates with generalized linear models accounting for healthy vaccinee effects. |
| 000411 (2012) |
Joanne M. Langley [Canada] ; David W. Scheifele ; Caroline Quach ; Otto G. Vanderkooi ; Brian Ward ; Shelly Mcneil ; Simon Dobson ; James D. Kellner ; Susan Kuhn ; Tobias Kollman ; Donna Mackinnon-Cameron ; Bruce Smith ; Yan Li ; Scott A. Halperin | Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study. |
| 000424 (2012) |
Salaheddin M. Mahmud [Canada] ; Paul Van Caeseele ; Gregory Hammond ; Carol Kurbis ; Tim Hilderman ; Lawrence Elliott | No association between 2008-09 influenza vaccine and influenza A(H1N1)pdm09 virus infection, Manitoba, Canada, 2009. |
| 000450 (2012) |
D M Skowronski [Canada] ; G. De Serres ; N Z Janjua ; J L Gardy ; V. Gilca ; M. Dionne ; M E Hamelin ; C. Rhéaume ; G. Boivin | Cross-reactive antibody to swine influenza A(H3N2) subtype virus in children and adults before and after immunisation with 2010/11 trivalent inactivated influenza vaccine in Canada, August to November 2010. |
| 000511 (2011) |
Corina Nailescu [États-Unis] ; Xiyan Xu ; Hong Zhou ; Henrietta Hall ; Amy C. Wilson ; Jeffrey D. Leiser ; Deepa H. Chand ; Rudolph P. Valentini ; Diane Hebert ; John D. Mahan | Influenza vaccine after pediatric kidney transplant: a Midwest Pediatric Nephrology Consortium study. |
| 000518 (2011) |
Cécile L. Tremblay [Canada] ; Danielle Rouleau ; Claude Fortin ; Emil Toma ; Mohamed Sylla ; Lise Cyr ; Serge Cote ; Mariana Baz ; John Sampalis ; Lydie Trautman ; Rafick-Pierre Sékaly ; Guy Boivin | Immunogenicity and tolerability of an inactivated and adjuvanted pandemic H1N1 influenza vaccine, in HIV-1-infected patients. |
| 000614 (2010) |
Glendie Marcelin [États-Unis] ; Hilliary M. Bland ; Nicholas J. Negovetich ; Matthew R. Sandbulte ; Ali H. Ellebedy ; Ashley D. Webb ; Yolanda S. Griffin ; Jennifer L. Debeauchamp ; Janet E. Mcelhaney ; Richard J. Webby | Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza A(H1N1) 2009 virus in an age-dependent manner. |
